The Association for the Accreditation of Human Research Protection Programs (AAHRPP) is pleased to announce that eight new organizations have been awarded Full Accreditation at the most recent meeting of its Council on Accreditation. AAHRPP's accreditation program is the field's primary vehicle for setting uniform, high standards across the research enterprise—in both the private and non-profit sectors. Accreditation internationally recognizes individual HRPPs that have demonstrated their commitment to providing strong protections to research participants and is capable of delivering on that promise. The list of accredited organization now includes the following organizations:
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.